Baxter International, Inc. (BAX) Launches HEMOPATCH, an Innovative Sealing Hemostat, in European Union
10/23/2013 10:16:11 AM
DEERFIELD, Ill.--(BUSINESS WIRE)--Baxter International Inc. (NYSE:BAX) today announced the launch of HEMOPATCH Sealing Hemostat, a novel collagen-based hemostatic device, following CE mark approval in Europe. HEMOPATCH is a resorbable hemostatic device used for surgical procedures when control of bleeding by pressure, ligature or conventional procedures is either ineffective or impractical. The development of HEMOPATCH combined Baxter’s expertise in collagen, internal coagulation processes, and PEG (polyethylene glycol) technology platforms.
Help employers find you! Check out all the jobs and post your resume.
comments powered by